Bullish Moving Averages
0
Bearish Moving Averages
16
Back Stocks profile
Stock analysis tool for investors
Performance
Open Price
23.70Prev. Close
27.0200Volume
17064.00Value
395714.16Fundamentals
Market Cap
47.10
Price to Earnings
27.20
Price to Book Value
1.90
Dividend Yield
0.00
PE to Growth
8.80
Op Revenue TTM
12.18
Net Profit TTM
1.73
Cash From Operating Activity
4.01
Return on Equity %
7.48
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
95.6
Week
86.5
Month
71.6
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
23.31
PIVOT
First Resistance
23.63
Second Resistance
24.11
Third Resistance
24.43
First Support
22.83
Second Support
22.51
Third Support
22.03
Relative Strength Index
37.08
Money Flow Index
11.2
MACD
-0.58
MACD Signal
-0.48
Average True Range
1.27
Average Directional Index
15.67
Rate of Change (21)
-11.58
Rate of Change (125)
-20.83
Commodity Channel Index
-101.2
Williams %R
-84.7
BETA
1 Month
0.47
3 Month
0.77
1 Year
0.38
3 Year
0.12
PRICE CHANGE ANALYSIS
↓ -0.86%
1 Week
Low
High
22.82
24.38
↓ -8.84%
1 Month
Low
High
22.66
26.59
↓ -12.16%
3 Months
Low
High
22.55
30.5
↓ -29.88%
6 Months
Low
High
22.55
34.9
↓ -34.75%
1 Year
Low
High
22.55
37.24
29 Jun 2024
Tejnaksh Healthcare Ltd - 539428 - Closure of Trading Window
Please find Letter attached
30 May 2024
Tejnaksh Healthcare Ltd - 539428 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Please Find Annual Secretarial Compliance Report.
28 May 2024
Tejnaksh Healthcare Ltd - 539428 - Submission Of Audited Financial Results (Standalone & Consolidated) For The Quarter Ended And Year End On 31Th March, 2024.
Please find enclosed Audited Financial Results for the Year Ended 31-03-2024
28 May 2024
Tejnaksh Healthcare Ltd - 539428 - Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 And Disclosure Pursuant To Regulation 30
We wish to inform you that the meeting of the Board of Directors of the Company held Today i.e. Tuesday, May 28, 2024 at A 601, Floor No.6, Kailash Business Park, Veer Savarkar Marg, Vikroli - West, Mumbai - 400079 at 2 p.m., and has transacted the following businesses: 1. Considered and approved Audited Financial Results (Standalone & Consolidated) for the quarter and Year ended on March 31, 2024 and Auditors Report thereon, in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; 2. A declaration pursuant to Regulation 33(3)(d) of the SEBI (LODR) Regulations, 2015, regarding unmodified opinion of the Statutory Auditors on the annual financial results for the financial year ended March 31, 2024. - The meeting of Board of Directors commenced at 2.00 pm and concluded at 5.30 pm.
17 May 2024
Tejnaksh Healthcare Ltd - 539428 - Board Meeting Intimation for Regulation 29 SEBI Regulation 2015
Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 ,inter alia, to consider and approve 1. To Consider and approve Audited Financial Results (Standalone & Consolidated) for the Quarter and year ended March 31, 2024. 2. Any other matter with the permission of the Chair.
19 Apr 2024
Tejnaksh Healthcare Ltd - 539428 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Tejnaksh Healthcare Ltd 2 CIN NO. L85100MH2008PLC179034 3 Report filed for FY 2022-2023 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* FY 2022-23,FY 2023-24 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) NA 8Quantum of (d), which has been met from (c)(e)* NA 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* NA Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)FY 2022-23,FY 2023-24 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Afrin ShaikhDesignation :-Company Secretary Name of the Chief Financial Officer :- Ramesh Kuwar Designation : -CFO Date: 19/04/2024
19 Apr 2024
Tejnaksh Healthcare Ltd - 539428 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyTejnaksh Healthcare Ltd 2CIN NO.L85100MH2008PLC179034 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 4.75 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Afrin Shaikh Designation: Company Secretary EmailId: [email protected] Name of the Chief Financial Officer: Ramesh Kuwar Designation: CFO EmailId: [email protected] Date: 19/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
17 Apr 2024
Tejnaksh Healthcare Ltd - 539428 - Yearly Compliance Certificate (Financial Year Ended On March 31St, 2024
Please Find Letter Attached
16 Apr 2024
Tejnaksh Healthcare Ltd - 539428 - Submission Of Certificate Under Regulation 7(3) Of SEBI (LODR) Regulation, 2015 For The Year Ended On 31.03.2024
Please Find letter attached.
15 Apr 2024
Tejnaksh Healthcare Ltd - 539428 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please Find Compliance Certificate under Reg.74(5) of SEBI(DP)Regulation 2018.
